Wednesday, 13 January 2021

Investorideas.com - Psychedelic Stock News: Neonmind (CSE: NEON) Engages Dr. C. Laird Birmingham To Develop Protocols For Phase 2 Clinical Trial Using Psilocybin To Treat Obesity

Investorideas.com - Psychedelic Stock News: Neonmind (CSE: NEON) Engages Dr. C. Laird Birmingham To Develop Protocols For Phase 2 Clinical Trial Using Psilocybin To Treat Obesity

No comments:

Post a comment

Investorideas.com - Cannabis Stock News: Highly Dutch (TSX: $TGOD.TO) (US: $TGODF) Expands Product Lineup, Adds Amsterdam Sativa-Organically grown high-THC Sativa flower

Investorideas.com - Cannabis Stock News: Highly Dutch (TSX: $TGOD.TO) (US: $TGODF) Expands Product Lineup, Adds Amsterdam Sativa-Organically...